{"id":"W2588008593","doi":"10.1016/j.revmed.2017.01.004","title":"Opportunistic autoimmunity secondary to cancer immunotherapy (OASI): An emerging challenge","year":2017,"lang":"en","type":"review","venue":"La Revue de Médecine Interne","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital Saint-François d'Assise","funders":"","keywords":"Immunotherapy; Medicine; Pembrolizumab; Cancer immunotherapy; Autoimmunity; Melanoma; Oncology; Cancer; Metastatic melanoma; Adjuvant; Adverse effect; Nivolumab; Immunology; Internal medicine; Immune system; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010888,0.0008421096,0.002957773,0.000484029,0.0001720684,0.0001541149,0.001138201,0.0005865566,0.001926296],"category_scores_gemma":[0.0001144128,0.0007273753,0.001012614,0.0002170778,0.0001705924,0.0001516266,0.0002116569,0.001372652,0.00005836732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008074507,"about_ca_system_score_gemma":0.001211269,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00153887,"about_ca_topic_score_gemma":0.0004189068,"domain_scores_codex":[0.9967273,0.0003373879,0.001183328,0.0008066788,0.0002774335,0.0006678785],"domain_scores_gemma":[0.9962021,0.0001702017,0.0007785492,0.002307833,0.0001308576,0.0004104704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005428394,0.0003402723,0.00006529297,0.009049916,0.001221744,0.0004866088,0.0004444385,1.792563e-7,0.00009086707,0.000111224,0.001268502,0.9863781],"study_design_scores_gemma":[0.002019471,0.000666869,0.00111353,0.04131563,0.0007730295,0.0009929672,0.00004376854,0.00001128836,0.000004245335,0.00003282182,0.9523438,0.0006825955],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002115236,0.9882435,0.0001308303,0.001815303,0.001169808,0.001430472,0.0002686436,0.0002725248,0.006457354],"genre_scores_gemma":[0.0005941055,0.9857382,0.0002467386,0.00071051,0.001310454,0.0005553052,0.0004062073,0.0003669926,0.01007154],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9856955,"threshold_uncertainty_score":0.9995177,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.135948062588993,"score_gpt":0.4295305622358054,"score_spread":0.2935824996468124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}